Yahoo
Shenzhen - Delayed Quote CNY

B-SOFT Co.,Ltd. (300451.SZ)

3.4500 -0.1000 (-2.82%)
At close: 3:04:16 PM GMT+8
Chart Range Bar
Loading chart for 300451.SZ
  • Previous Close 3.5500
  • Open 3.3700
  • Bid 3.4400 x --
  • Ask 3.4500 x --
  • Day's Range 3.4400 - 3.5300
  • 52 Week Range 3.0600 - 6.9900
  • Volume 24,817,777
  • Avg. Volume 24,710,789
  • Market Cap (intraday) 5.344B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3800
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date May 31, 2024
  • 1y Target Est 6.03

B-SOFT Co.,Ltd. operates in the healthcare information technology industry in China. The company offers Huikang·Yunshu Intelligent Body, a medical AI agent of Huikang. It also provides outpatient registration and appointment center, medical technology appointment center, inpatient and outpatient services, and hospital cloud platform; and big data and artificial intelligence, hospital-wide medical-technical integration, mobile intelligent healthcare, hospital multidisciplinary consultation, clinical decision, b-soft overall solution for epidemic prevention and control, and Hi-HIS. In addition, the company offers management decision support, intelligent comprehensive management, hospital medical insurance risk management, performance management, intelligent management application, refined management system for low value consumables, consumables traceability management system, and consumables trading supervision and drug trade supervision platform; and intelligent IoT, multidisciplinary telemedicine, and 5G prehospital emergency. Further, it provides medical security information platform, DRG/DIP hospital side applications, and single disease quality management control; intelligent health; and city level health services platform and internet plus nursing services. B-SOFT Co.,Ltd. was founded in 1997 and is headquartered in Hangzhou, China.

www.bsoft.com.cn

3,731

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300451.SZ
28.72%
SSE Composite Index (000001.SS)
8.05%

1-Year Return

300451.SZ
28.72%
SSE Composite Index (000001.SS)
8.95%

3-Year Return

300451.SZ
54.25%
SSE Composite Index (000001.SS)
19.32%

5-Year Return

300451.SZ
58.97%
SSE Composite Index (000001.SS)
4.51%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY22
Revenue 462.99M
Earnings 92.25M
Profit Margin 19.92%

Q3

FY19

Q3

FY20

Q4

FY20

Q1

FY22

0
100M
200M
300M
400M
0.0%
5.0%
10.0%
15.0%

Analyst Insights

View More

Analyst Price Targets

6.00
6.03 Average
3.4500 Current
6.05 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -67.22%

  • Return on Assets (ttm)

    -6.13%

  • Return on Equity (ttm)

    -14.53%

  • Revenue (ttm)

    878.3M

  • Net Income Avi to Common (ttm)

    -590.39M

  • Diluted EPS (ttm)

    -0.3800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    339.94M

  • Total Debt/Equity (mrq)

    3.65%

  • Levered Free Cash Flow (ttm)

    -340.56M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: